Proposed change of auditor
Filed with HKEX · Stock code 1498 · · 6 pages · English
(Incorporated in the Cayman Islands with limited liability) (Stock code: 1498) PROPOSED CHANGE OF AUDITOR This announcement is made by PuraPharm Corporation Limited (the “Company”, together with its subsidiaries, the “Group”) pursuant to Rule 13.51(4) of the Rules Governing the Listing of Securities (the “Listing Rule”) on The Stock Exchange of Hong Kong Limited (the “Stock Exchange”). RESIGNATION
Earlier from PuraPharm
- Resignation of chief financial officer, change of company secretary and authorised representative
- (I) proposed re-election of retiring directors; (II) proposed grant of general mandates to buy back shares and issue new shares; (iii) proposed refreshment of Scheme Mandate Limit under the share option scheme; (IV) proposed change of company name; (v) proposed amendments to the Articles of Association of the company; and notice of annual general meeting
- Extension of long stop date for connected transaction
- PuraPharm: Connected transaction - acquisition of intellectual properties
- Profit alert
Later from PuraPharm
- Interim Report 2026
- Notification Letter to Registered Shareholders and Change Request Form - 2026 Interim Report
- Notification Letter to Non-registered Shareholders and Request Form - 2026 Interim Report
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Proposed change of auditor and notice of extraordinary general meeting
Follow PuraPharm into a list and get an email when it puts out news.
Follow PuraPharm